rs762950368

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4BP6BS2

The NM_001271.4(CHD2):ā€‹c.4165A>Cā€‹(p.Lys1389Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000693 in 1,586,574 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K1389E) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.000020 ( 0 hom., cov: 32)
Exomes š‘“: 0.0000056 ( 0 hom. )

Consequence

CHD2
NM_001271.4 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 4.43
Variant links:
Genes affected
CHD2 (HGNC:1917): (chromodomain helicase DNA binding protein 2) The CHD family of proteins is characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CHD2. . Gene score misZ 5.2052 (greater than the threshold 3.09). Trascript score misZ 6.0204 (greater than threshold 3.09). GenCC has associacion of gene with developmental and epileptic encephalopathy 94, complex neurodevelopmental disorder, myoclonic-astatic epilepsy, Lennox-Gastaut syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.2696948).
BP6
Variant 15-93002204-A-C is Benign according to our data. Variant chr15-93002204-A-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 474390.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1}.
BS2
High AC in GnomAdExome4 at 8 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CHD2NM_001271.4 linkuse as main transcriptc.4165A>C p.Lys1389Gln missense_variant 33/39 ENST00000394196.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CHD2ENST00000394196.9 linkuse as main transcriptc.4165A>C p.Lys1389Gln missense_variant 33/395 NM_001271.4 P1O14647-1

Frequencies

GnomAD3 genomes
AF:
0.0000199
AC:
3
AN:
151098
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000199
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000557
AC:
8
AN:
1435476
Hom.:
0
Cov.:
30
AF XY:
0.00000840
AC XY:
6
AN XY:
713886
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.07e-7
Gnomad4 OTH exome
AF:
0.000118
GnomAD4 genome
AF:
0.0000199
AC:
3
AN:
151098
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
73762
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000199
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000189
ExAC
AF:
0.00000825
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 12, 2019The p.K1389Q variant (also known as c.4165A>C), located in coding exon 32 of the CHD2 gene, results from an A to C substitution at nucleotide position 4165. The lysine at codon 1389 is replaced by glutamine, an amino acid with some similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Developmental and epileptic encephalopathy 94 Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 06, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Benign
-0.42
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.14
.;T
Eigen
Uncertain
0.32
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.95
D;D
M_CAP
Benign
0.038
D
MetaRNN
Benign
0.27
T;T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
1.9
L;L
MutationTaster
Benign
0.99
D;D
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-1.3
.;N
REVEL
Benign
0.066
Sift
Benign
0.097
.;T
Sift4G
Benign
0.36
T;T
Polyphen
0.94
P;P
Vest4
0.39
MutPred
0.26
Loss of methylation at K1389 (P = 0.0129);Loss of methylation at K1389 (P = 0.0129);
MVP
0.54
MPC
0.42
ClinPred
0.54
D
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.14
gMVP
0.30

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs762950368; hg19: chr15-93545434; COSMIC: COSV101244985; COSMIC: COSV101244985; API